Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a multi-strain probiotic combination containing Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5, Lactobacillus plantarum, and Saccharomyces boulardii. These strains are among the most clinically studied probiotics for digestive and immune health. - **Bifidobacterium lactis BB-12** and **Lactobacillus acidophilus LA-5** have been shown to help alleviate chronic constipation in elderly patients, reduce symptoms of ulcerative colitis after surgery, improve tolerance to lactose in lactose-intolerant individuals, and reduce the severity of antibiotic-associated diarrhea[1][7]. They exhibit anti-inflammatory effects by modulating NF-kB signaling pathways and reducing pro-inflammatory cytokines such as TNF-alpha[2][5]. - **Lactobacillus plantarum** is known for its ability to support gut barrier function and modulate immune responses (general knowledge). - **Saccharomyces boulardii** is a non-pathogenic yeast widely used for prevention or treatment of antibiotic-associated diarrhea and other gastrointestinal disorders (general knowledge). The combination acts primarily through modulation of the gut microbiota composition, enhancement of mucosal barrier integrity, competitive exclusion of pathogens, production of beneficial metabolites (such as short-chain fatty acids), immunomodulation via interaction with pattern recognition receptors like TLR2 on intestinal epithelial cells[2], suppression of inflammatory mediators (e.g., COX-2), reduction in intestinal permeability, and restoration or maintenance of healthy bowel function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bifidobacterium lactis BB-12 + lactobacillus acidophilus LA-5 + lactobacillus plantarum + saccharomyces boulardii.